The changes of PCR ribotype and antimicrobial resistance of Clostridium difficile in a tertiary care hospital over 10 years

J Med Microbiol. 2014 Jun;63(Pt 6):819-823. doi: 10.1099/jmm.0.072082-0. Epub 2014 Apr 2.

Abstract

The aims of this study were to investigate any change in PCR ribotypes and to determine the antimicrobial resistance of common PCR ribotypes over a 10-year period in a tertiary care hospital. We conducted PCR ribotyping, antimicrobial susceptibility testing and DNA gyrase sequencing to identify changes in 1407 Clostridium difficile non-duplicated isolates obtained between 2000 and 2009. A total of 74 different ribotypes were found. The most prevalent ribotype was ribotype 001 (26.1 %). The prevalence of ribotype 017 was 17 % and that of ribotype 014/020 was 9.6 %. Ribotyping showed that the prevalence of ribotype 001 decreased and the prevalence of ribotypes 017, 014/020 and 018 increased over the 10 years. Antimicrobial resistance rates in prevalent ribotypes were: clindamycin, 81 %; cefotetan, 19 %; moxifloxacin, 42 %; imipenem, 8 %; ciprofloxacin, 100 % and erythromycin, 80 %. Ribotype 018 showed greater antimicrobial resistance than other ribotypes. All ribotype 018 strains showing moxifloxacin resistance had a substitution of a gyrA coding amino acid (Thr82 to Ile). This study will help the understanding of PCR ribotype trends and antimicrobial resistance of C. difficile in Korea.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Toxins / genetics
  • Bacterial Toxins / metabolism
  • Clostridioides difficile / drug effects*
  • Clostridioides difficile / genetics*
  • DNA Gyrase / genetics
  • DNA Gyrase / metabolism
  • Drug Resistance, Bacterial*
  • Gene Expression Regulation, Bacterial / physiology
  • Humans
  • Mutation
  • Polymerase Chain Reaction / methods*
  • Ribotyping*
  • Tertiary Care Centers
  • Time Factors

Substances

  • Anti-Bacterial Agents
  • Bacterial Toxins
  • DNA Gyrase